Recently added
This page was added on 04 June 2018.
Updates made
This page was updated on [date-counter-updated-date]. View history of updates
Sponsor
Seqirus
Administration route
Intramuscular injection
Vaccine group
Adults aged ≥50 years only
Description:
Registered for use in people aged ≥50 years.
Adjuvanted trivalent inactivated influenza vaccine, surface antigen.
Each 0.5 mL monodose pre-filled syringe contains:
- 15 µg haemagglutinin of each of the 3 recommended influenza virus strains.
These are adjuvanted with MF59C.1. The adjuvant includes:
- 9.75 mg squalene
- 1.175 mg polysorbate 80
- 1.175 mg sorbitan trioleate
- 0.66 mg sodium citrate dihydrate
- 0.04 mg citric acid monohydrate
May contain traces of:
- kanamycin sulfate
- neomycin sulfate
- formaldehyde (≤ 1 µg)
- cetrimonium bromide (≤ 18 µg)
- ovalbumin (≤ 1 µg)
- sucrose
- hydrocortisone
For Product Information and Consumer Medicine Information about Fluad visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.
Page history
Last updated
Last reviewed
Related diseases